• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测前列腺癌根治术后10年复发概率的术前列线图。

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.

作者信息

Stephenson Andrew J, Scardino Peter T, Eastham James A, Bianco Fernando J, Dotan Zohar A, Fearn Paul A, Kattan Michael W

机构信息

Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

出版信息

J Natl Cancer Inst. 2006 May 17;98(10):715-7. doi: 10.1093/jnci/djj190.

DOI:10.1093/jnci/djj190
PMID:16705126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2242430/
Abstract

An existing preoperative nomogram predicts the probability of prostate cancer recurrence, defined by prostate-specific antigen (PSA), at 5 years after radical prostatectomy based on clinical stage, serum PSA, and biopsy Gleason grade. In an updated and enhanced nomogram, we have extended the predictions to 10 years, added the prognostic information of systematic biopsy results, and enabled the predictions to be adjusted for the year of surgery. Cox regression analysis was used to model the clinical information for 1978 patients treated by two high-volume surgeons from our institution. The nomogram was externally validated on an independent cohort of 1545 patients with a concordance index of 0.79 and was well calibrated with respect to observed outcome. The inclusion of the number of positive and negative biopsy cores enhanced the predictive accuracy of the model. Thus, a new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy.

摘要

现有的术前列线图可根据临床分期、血清前列腺特异性抗原(PSA)和活检Gleason分级预测根治性前列腺切除术后5年前列腺癌复发的概率(以PSA定义)。在一个更新和增强的列线图中,我们将预测时间延长至10年,增加了系统活检结果的预后信息,并使预测能够根据手术年份进行调整。使用Cox回归分析对我们机构两位高年资外科医生治疗的1978例患者的临床信息进行建模。该列线图在一个由1545例患者组成的独立队列中进行了外部验证,一致性指数为0.79,并且在观察结果方面校准良好。纳入阳性和阴性活检核心的数量提高了模型的预测准确性。因此,一种新的术前列线图能够对根治性前列腺切除术后长达10年的前列腺癌复发提供可靠的预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f216/2242430/01d1a23b60cf/nihms-38087-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f216/2242430/01d1a23b60cf/nihms-38087-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f216/2242430/01d1a23b60cf/nihms-38087-f0001.jpg

相似文献

1
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.预测前列腺癌根治术后10年复发概率的术前列线图。
J Natl Cancer Inst. 2006 May 17;98(10):715-7. doi: 10.1093/jnci/djj190.
2
Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.预测前列腺癌根治术后生化复发男性前列腺癌特异性死亡率的列线图
Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.
3
Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer.前列腺癌根治性前列腺切除术后疾病复发的术后列线图。
J Clin Oncol. 1999 May;17(5):1499-507. doi: 10.1200/JCO.1999.17.5.1499.
4
Postoperative prostate-specific antigen nadir improves accuracy for predicting biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) and Duke Prostate Center databases.术后前列腺特异性抗原(PSA)最低值可提高根治性前列腺切除术后预测生化复发的准确性:来自共享平等获取区域癌症医院(SEARCH)和杜克前列腺中心数据库的结果。
Int J Urol. 2010 Nov;17(11):914-22. doi: 10.1111/j.1442-2042.2010.02631.x. Epub 2010 Sep 30.
5
Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.一种预后工具的跨文化验证:以卡坦术前列线图作为前列腺癌根治术后复发预测指标为例
BJU Int. 2009 Sep;104(6):813-7; discussion 817-8. doi: 10.1111/j.1464-410X.2009.08473.x. Epub 2009 Feb 27.
6
Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.癌症阳性核心的百分比在预测前列腺癌根治术后癌症复发方面比前列腺特异性抗原是更好的术前预测指标。
J Urol. 2004 Apr;171(4):1492-9. doi: 10.1097/01.ju.0000118690.05943.c0.
7
A validation of two preoperative nomograms predicting recurrence following radical prostatectomy in a cohort of European men.两项术前列线图在一组欧洲男性中预测根治性前列腺切除术后复发情况的验证
Urol Oncol. 2002 Jul-Aug;7(4):141-6. doi: 10.1016/s1078-1439(02)00177-1.
8
Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer.预测前列腺癌根治性前列腺切除术后早期复发概率的列线图。
J Urol. 2009 Feb;181(2):601-7; discussion 607-8. doi: 10.1016/j.juro.2008.10.033. Epub 2008 Dec 13.
9
External validation of preoperative nomograms predicting biochemical recurrence after radical prostatectomy.术前列线图预测根治性前列腺切除术后生化复发的外部验证。
Jpn J Clin Oncol. 2013 Dec;43(12):1255-60. doi: 10.1093/jjco/hyt154. Epub 2013 Oct 21.
10
Comparison of observed biochemical recurrence-free survival in patients with low PSA values undergoing radical prostatectomy and predictions of preoperative nomogram.接受根治性前列腺切除术的低PSA值患者观察到的无生化复发生存率与术前列线图预测结果的比较。
Urology. 2009 May;73(5):1098-103. doi: 10.1016/j.urology.2008.07.052. Epub 2009 Mar 17.

引用本文的文献

1
Identification of novel gene-based risk score for prognosis in prostate cancer.前列腺癌预后新型基因风险评分的鉴定
Sci Rep. 2025 Jul 1;15(1):22128. doi: 10.1038/s41598-025-03800-3.
2
Real-World Management of High-Risk Prostate Cancer Post-Radical Prostatectomy: Insights from a Regional Quality Collaborative.根治性前列腺切除术后高危前列腺癌的真实世界管理:来自区域质量协作的见解
Cancers (Basel). 2025 May 8;17(10):1600. doi: 10.3390/cancers17101600.
3
Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate-Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice.基于临床实践数据估算前列腺切除术后患者进行前列腺特异性膜抗原正电子发射断层扫描的最佳时间
Biom J. 2025 Jun;67(3):e70058. doi: 10.1002/bimj.70058.
4
Development and validation of tryptophan metabolism-related risk model and molecular subtypes for predicting postoperative biochemical recurrence in prostate cancer.用于预测前列腺癌术后生化复发的色氨酸代谢相关风险模型及分子亚型的开发与验证
Transl Androl Urol. 2025 Apr 30;14(4):1082-1110. doi: 10.21037/tau-2025-39. Epub 2025 Apr 27.
5
Preoperative MRI-based predictive model for biochemical recurrence following radical prostatectomy.基于术前磁共振成像的前列腺癌根治术后生化复发预测模型
Abdom Radiol (NY). 2025 Mar 18. doi: 10.1007/s00261-025-04877-0.
6
Long-term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image-guided Radiotherapy for Postoperative Prostate Cancer Patients.使用螺旋断层放疗结合图像引导放疗对前列腺癌术后患者进行挽救性放疗的长期疗效
Cancer Diagn Progn. 2025 Mar 3;5(2):189-197. doi: 10.21873/cdp.10429. eCollection 2025 Mar-Apr.
7
Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study.血清中GPX4、NDUFS4、PRDX5和TXNRD2水平升高作为前列腺癌患者去势抵抗的预测生物标志物:一项探索性研究。
Br J Cancer. 2025 Apr;132(6):543-557. doi: 10.1038/s41416-025-02947-0. Epub 2025 Feb 3.
8
Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy.前列腺MRI与临床病理风险计算器用于预测根治性前列腺切除术中前列腺外扩展的侧别。
Prostate Cancer Prostatic Dis. 2025 Jan 7. doi: 10.1038/s41391-024-00928-7.
9
Post-Prostatectomy Magnetic Resonance-Guided Radiotherapy on a 1.5 Tesla Magnetic Resonance Integrated Linear Accelerator: Feasibility, Toxicity, and Preliminary Clinical Outcomes.1.5特斯拉磁共振一体化直线加速器引导下前列腺切除术后的磁共振引导放疗:可行性、毒性及初步临床结果
Asia Pac J Clin Oncol. 2025 Jun;21(3):247-255. doi: 10.1111/ajco.14144. Epub 2024 Dec 4.
10
Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis prediction.原发性前列腺癌蛋白质组全景分析揭示了用于预后预测的 16 种蛋白质面板。
Cell Rep Med. 2024 Aug 20;5(8):101679. doi: 10.1016/j.xcrm.2024.101679.

本文引用的文献

1
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition.前列腺癌根治术后生化复发的定义:标准化定义提案
J Clin Oncol. 2006 Aug 20;24(24):3973-8. doi: 10.1200/JCO.2005.04.0756.
2
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy.预测前列腺癌根治术后10年复发概率的术后列线图。
J Clin Oncol. 2005 Oct 1;23(28):7005-12. doi: 10.1200/JCO.2005.01.867.
3
Prostate cancer and the Will Rogers phenomenon.前列腺癌与威尔·罗杰斯现象
J Natl Cancer Inst. 2005 Sep 7;97(17):1248-53. doi: 10.1093/jnci/dji248.
4
Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.切缘重要吗?根治性前列腺切除标本中手术切缘阳性的预后意义。
J Urol. 2005 Sep;174(3):903-7. doi: 10.1097/01.ju.0000169475.00949.78.
5
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.根治性前列腺切除术后生化复发后前列腺癌特异性死亡风险。
JAMA. 2005 Jul 27;294(4):433-9. doi: 10.1001/jama.294.4.433.
6
Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure).使用基于社区的队列验证前列腺癌复发的卡坦术前列线图:前列腺癌战略泌尿外科研究项目(CAPSURE)的结果
J Urol. 2004 Jun;171(6 Pt 1):2255-9. doi: 10.1097/01.ju.0000127733.01845.57.
7
Is year of radical prostatectomy a predictor of outcome in prostate cancer?前列腺癌根治术后的年份是前列腺癌预后的预测指标吗?
J Urol. 2004 Feb;171(2 Pt 1):692-6. doi: 10.1097/01.ju.0000107260.98031.0e.
8
Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens.根治性前列腺切除标本中,不同外科医生的手术切缘阳性率存在差异。
J Urol. 2003 Dec;170(6 Pt 1):2292-5. doi: 10.1097/01.ju.0000091100.83725.51.
9
Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.为前列腺癌男性患者提供咨询:一种预测小的、中度分化的局限性肿瘤存在的列线图。
J Urol. 2003 Nov;170(5):1792-7. doi: 10.1097/01.ju.0000091806.70171.41.
10
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer.添加白细胞介素-6可溶性受体和转化生长因子β1可改善术前列线图,用于预测临床局限性前列腺癌患者的生化进展。
J Clin Oncol. 2003 Oct 1;21(19):3573-9. doi: 10.1200/JCO.2003.12.037. Epub 2003 Aug 11.